Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Byg Med Design ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.6% 1.6%   Bankruptcy risk   8.5% 8.2% 10.8% 3.6% 28.0% 17.5% 17.3% 17.3%   Credit score (0-100)   30 31 22 51 1 8 9 9   Credit rating   BB BB BB BBB B B BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 -0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   616 238 503 1,145 12.1 368 0.0 0.0   EBITDA   46.0 -98.9 81.9 494 -349 1.1 0.0 0.0   EBIT   13.9 -143 16.6 443 -396 -42.4 0.0 0.0   Pre-tax profit (PTP)   18.1 -144.9 8.3 439.4 -405.8 -47.1 0.0 0.0   Net earnings   13.1 -114.0 4.7 341.3 -400.6 -47.1 0.0 0.0   Pre-tax profit without non-rec. items   18.1 -145 8.3 439 -406 -47.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 170 153 113 72.0 31.4 0.0 0.0   Shareholders equity total   157 42.7 47.4 389 -69.0 -116 -166 -166   Interest-bearing liabilities   0.0 198 0.0 0.0 0.0 0.0 166 166   Balance sheet total (assets)   344 392 500 860 315 366 0.0 0.0   Net Debt   -113 198 -101 -455 -29.8 -161 166 166     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   616 238 503 1,145 12.1 368 0.0 0.0   Gross profit growth   249.7% -61.3% 111.3% 127.7% -98.9% 2,933.1% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   344 392 500 860 315 366 0 0   Balance sheet change%   58.2% 13.9% 27.5% 71.9% -63.3% 16.0% -100.0% 0.0%   Added value   46.0 -98.9 81.9 494.2 -344.6 1.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -32 125 -82 -92 -88 -84 -31 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 -1.0 1.0 2.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   2.3% -60.3% 3.3% 38.6% -3,266.9% -11.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   6.7% -38.8% 3.7% 65.1% -63.7% -9.8% 0.0% 0.0%   ROI %   12.5% -71.8% 11.4% 200.5% -201.1% 0.0% 0.0% 0.0%   ROE %   8.7% -114.3% 10.5% 156.5% -113.8% -13.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   45.5% 10.9% 9.5% 45.2% -18.0% -24.1% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -245.9% -200.4% -123.7% -92.0% 8.5% -15,363.0% 0.0% 0.0%   Gearing %   0.0% 464.0% 0.0% 0.0% 0.0% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 1.9% 8.3% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.8 0.6 0.8 1.6 0.6 0.7 0.0 0.0   Current Ratio   1.8 0.6 0.8 1.6 0.6 0.7 0.0 0.0   Cash and cash equivalent   113.0 0.0 101.3 454.7 29.8 161.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   157.6 -127.0 -105.8 281.4 -141.0 -147.4 -83.0 -83.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   46 -99 82 494 -345 1 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   46 -99 82 494 -349 1 0 0   EBIT / employee   14 -143 17 443 -396 -42 0 0   Net earnings / employee   13 -114 5 341 -401 -47 0 0